Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $16.5 in the prior trading day, Sotera Health Co (NASDAQ: SHC) closed at $16.2, down -1.82%. In other words, the price has decreased by -$1.82 from its previous closing price. On the day, 1.78 million shares were traded. SHC stock price reached its highest trading level at $16.5 during the session, while it also had its lowest trading level at $15.96.
Ratios:
Our goal is to gain a better understanding of SHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 32.73. For the most recent quarter (mrq), Quick Ratio is recorded 2.21 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 4.60 whereas as Long-Term Debt/Eq ratio is at 4.55.
On December 06, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $14.
On May 21, 2024, Piper Sandler started tracking the stock assigning a Neutral rating and target price of $13.Piper Sandler initiated its Neutral rating on May 21, 2024, with a $13 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 22 ’25 when Rutz Michael P sold 126,611 shares for $16.38 per share. The transaction valued at 2,074,306 led to the insider holds 450,204 shares of the business.
Rutz Michael P bought 126,611 shares of SHC for $2,040,969 on Aug 22 ’25. On Sep 06 ’24, another insider, WARBURG PINCUS & CO., who serves as the Director of the company, sold 15,000,000 shares for $15.03 each. As a result, the insider received 225,450,000 and left with 73,822,952 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4601561600 and an Enterprise Value of 6620923904. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 193.55, and their Forward P/E ratio for the next fiscal year is 18.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 16.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.09 while its Price-to-Book (P/B) ratio in mrq is 9.00. Its current Enterprise Value per Revenue stands at 5.888 whereas that against EBITDA is 12.604.
Stock Price History:
The Beta on a monthly basis for SHC is 1.85, which has changed by 0.06382978 over the last 52 weeks, in comparison to a change of 0.15109766 over the same period for the S&P500. Over the past 52 weeks, SHC has reached a high of $17.08, while it has fallen to a 52-week low of $9.53. The 50-Day Moving Average of the stock is 27.00%, while the 200-Day Moving Average is calculated to be 27.78%.
Shares Statistics:
The stock has traded on average 1.38M shares per day over the past 3-months and 1518410 shares per day over the last 10 days, according to various share statistics. A total of 284.05M shares are outstanding, with a floating share count of 153.31M. Insiders hold about 46.03% of the company’s shares, while institutions hold 52.89% stake in the company. Shares short for SHC as of 1755216000 were 13751828 with a Short Ratio of 9.97, compared to 1752537600 on 13682732. Therefore, it implies a Short% of Shares Outstanding of 13751828 and a Short% of Float of 8.9099996.
Earnings Estimates
The performance of Sotera Health Co (SHC) in the stock market is under the watchful eye of 7.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $0.24, with high estimates of $0.25 and low estimates of $0.23.
Analysts are recommending an EPS of between $0.8 and $0.78 for the fiscal current year, implying an average EPS of $0.79. EPS for the following year is $0.88, with 7.0 analysts recommending between $0.9 and $0.87.
Revenue Estimates
6 analysts predict $303.63M in revenue for the current quarter. It ranges from a high estimate of $306.1M to a low estimate of $299.33M. As of the current estimate, Sotera Health Co’s year-ago sales were $285.47MFor the next quarter, 6 analysts are estimating revenue of $305.62M. There is a high estimate of $311.08M for the next quarter, whereas the lowest estimate is $301M.
A total of 6 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.15B, resulting in an average revenue estimate of $1.16B. In the same quarter a year ago, actual revenue was $1.1BBased on 6 analysts’ estimates, the company’s revenue will be $1.23B in the next fiscal year. The high estimate is $1.24B and the low estimate is $1.22B.
